• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Cis-1,2,6-trimethylpiperazine;Dihydrochloride (CAS No. 1195782-28-5): A Comprehensive Overview in Modern Chemical Biology

Cis-1,2,6-trimethylpiperazine;Dihydrochloride, identified by the CAS number 1195782-28-5, is a compound of significant interest in the field of chemical biology and pharmaceutical research. This piperazine derivative has garnered attention due to its unique structural properties and potential applications in drug development. The dihydrochloride salt form enhances its solubility and stability, making it a valuable candidate for various biochemical and pharmacological studies.

The molecular structure of cis-1,2,6-trimethylpiperazine;Dihydrochloride features a piperazine ring substituted with three methyl groups at the 1, 2, and 6 positions, along with a dihydrochloride counterion. This configuration imparts specific steric and electronic properties that influence its interactions with biological targets. The cis configuration of the piperazine ring is particularly noteworthy, as it can affect binding affinity and metabolic pathways differently compared to its trans counterpart.

In recent years, Cis-1,2,6-trimethylpiperazine;Dihydrochloride has been explored for its potential role in modulating neurotransmitter systems. Piperazine derivatives are known for their ability to interact with various receptors and enzymes in the central nervous system. Preliminary studies suggest that this compound may have applications in the treatment of neurological disorders by influencing serotonin and dopamine pathways. Its dihydrochloride form enhances bioavailability, making it a promising candidate for further investigation.

The compound's structural similarity to other known bioactive molecules has also sparked interest in its pharmacological profile. Researchers have been particularly intrigued by its potential as an intermediate in the synthesis of more complex pharmaceutical agents. The unique combination of methyl groups in the piperazine ring provides a versatile scaffold for chemical modifications, enabling the development of novel derivatives with tailored biological activities.

Recent advancements in computational chemistry have allowed for more accurate predictions of the binding interactions between Cis-1,2,6-trimethylpiperazine;Dihydrochloride and biological targets. Molecular docking studies have revealed potential binding sites on enzymes and receptors relevant to neurodegenerative diseases. These findings align with experimental observations that indicate the compound's ability to modulate key signaling pathways involved in brain health.

The synthesis of Cis-1,2,6-trimethylpiperazine;Dihydrochloride involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets the stringent standards required for pharmaceutical applications. The dihydrochloride salt form is particularly advantageous due to its enhanced stability under various storage conditions.

In clinical research settings, Cis-1,2,6-trimethylpiperazine;Dihydrochloride is being evaluated for its therapeutic potential in preclinical models. Animal studies have demonstrated promising results in terms of efficacy and safety profiles. These findings are paving the way for human clinical trials aimed at assessing its effectiveness in treating specific neurological conditions. The compound's ability to cross the blood-brain barrier efficiently is a critical factor contributing to its potential as a drug candidate.

The chemical biology community has also been interested in exploring the mechanisms of action underlying the effects of Cis-1,2,6-trimethylpiperazine;Dihydrochloride. Investigating how this compound interacts with cellular components has provided insights into potential therapeutic targets and adverse effect profiles. Understanding these interactions at a molecular level is crucial for developing safer and more effective drugs.

The future prospects for Cis-1,2,6-trimethylpiperazine;Dihydrochloride are promising, with ongoing research efforts focused on expanding its applications in medicine. Collaborative projects between academic institutions and pharmaceutical companies are expected to yield novel derivatives with enhanced pharmacological properties. Additionally, advancements in bioprocessing techniques may improve production efficiency, making this compound more accessible for therapeutic use.

In conclusion, Cis-1,2,6-trimethylpiperazine;Dihydrochloride (CAS No. 1195782-28-5) represents a significant advancement in chemical biology research. Its unique structural features and potential applications in drug development make it a compelling subject of study. As research continues to uncover new insights into its biological effects and mechanisms of action, this compound is poised to play a vital role in shaping future therapeutic strategies.

• 1152110-26-3((R)-1,3-Dimethylpiperazine dihydrochloride)
• 1046788-71-9((2R,5s)-1,2,5-trimethylpiperazine hydrochloride)
• 1022094-05-8(1,3-Dimethylpiperazine hydrochloride)
• 485841-50-7((2S)-1,2-dimethylpiperazine dihydrochloride)
• 1152110-30-9((3S)-1,3-dimethylpiperazine;dihydrochloride)
• 884199-34-2(1-Isopropyl-(S )-2-methylpiperazine dihydrochloride)
• 1152110-23-0((2R)-1,2-Dimethylpiperazine dihydrochloride)
• 1630082-91-5((S)-1-Ethyl-3-methyl-piperazine dihydrochloride)
• 1630082-92-6((R)-1-Ethyl-3-methyl-piperazine dihydrochloride)
• 799557-83-8(Piperazine, 2-methyl-1-(1-methylethyl)-, hydrochloride, (2S)-)